Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin

This publication has 15 references indexed in Scilit:

• Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)- 1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ
  Biochemical Pharmacology, 2000
• DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia
  European Journal of Pharmacology, 1999
• Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
  Journal of Pharmaceutical Sciences, 1996
• Cyclodextrin Derivatives in Pharmaceutics
  Critical Reviews in Therapeutic Drug Carrier Systems, 1995
• The Pharmacokinetics of β-Cyclodextrin and Hydroxypropyl-β-cyclodextrin in the Rat
  Pharmaceutical Research, 1990
• Induced circular dichroism of cycloamylose complexes with meta- and para-disubstituted benzenes
  Bioorganic Chemistry, 1981
• Cyclodextrin Inclusion Compounds in Research and Industry
  Angewandte Chemie International Edition in English, 1980
• The Circular Dichroism Spectra of the β-Cyclodextrin Complex with Naphthalene Derivatives
  Bulletin of the Chemical Society of Japan, 1975
• Binding Specificity between Small Organic Solutes in Aqueous Solution: Classification of Some Solutes into Two Groups According to Binding Tendencies
  Journal of Pharmaceutical Sciences, 1970
• Some comments on the Benesi‐Hildebrand equation
  Recueil des Travaux Chimiques des Pays-Bas, 1956